Please ensure Javascript is enabled for purposes of website accessibility

Top Curaleaf Shareholders Extend Stock Lockup

By Eric Volkman - Oct 22, 2019 at 9:18AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares will be released on a timetable that ends in March 2021.

One important concern investors have about marijuana stock Curaleaf Holdings (CURLF -1.15%) seems to have been swept away. The company announced on Monday that its "core" shareholders have signed an agreement to extend the stock's lockup period.  

Curaleaf said that the shares will be "unlocked" under a release schedule. As of Monday, a maximum of 15% of previously locked shares could be sold. On the final day of every subsequent calendar quarter, an additional 15% will be released. Finally, on March 31, 2021, the last release will let go of the remaining 10% of locked shares.

Marijuana leaf on top of a pair of handcuffs.

Image source: Getty Images.

A lockup period is a stretch of time during which shares in a company that has gone public cannot be sold by insiders. Lockups can be mandated by law for stocks that have undergone the IPO process or agreed to by the shareholders subsequently. They are put in place to help prevent insiders from unloading shares as soon as possible and risking a broader sell-off throughout the stock market.

In the press release announcing its move, Curaleaf said that the key shareholders' approval "signals their ongoing support for the Company."

"We expect the new lock-up release schedule to reduce uncertainty regarding the release of currently locked-up shares and provide for a more orderly increase in the available float in the Company's shares," Curaleaf continued.

The company said that all "core" stockholders have indicated they will not sell any of their shares, even though they are now permitted to begin doing so. Those investors comprise around 75% of issued and outstanding Curaleaf stock, the company said.

This is not the first time that Curaleaf has stretched out its lockup period. In March, the core shareholders entered an agreement to lock up 249 million shares until Oct. 20. That number was around 81% of the total outstanding.

Extensions are not unusual in the still-very-young marijuana industry, which is full of businesses that only recently became publicly traded companies.

Several months before the aforementioned Curaleaf extension, Tilray's (TLRY) major stockholder stretched its lockup period into the second half of this year. It subsequently reached another agreement with that stockholder for it to sell its holdings only if certain conditions are met across a two-year time frame.

Tilray's and Curaleaf's peer Trulieve Cannabis (TCNNF 0.55%) has made two extensions this year, the latest of which locks up Trulieve's subordinate voting shares until July 25, 2020.

Smaller Curaleaf shareholders did not seem to be surprised or impressed with the new lockup period extension. The company's stock closed down by over 2% on Monday. Fellow "unlocker" Tilray, however, was up 5%, while Trulieve ended the day marginally higher. 

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$5.69 (-1.15%) $0.07
Tilray Stock Quote
Trulieve Cannabis Stock Quote
Trulieve Cannabis
$12.88 (0.55%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.